Baillie Gifford & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.6M | Buy |
212,479
+78,014
| +58% | +$34.7M | 0.07% | 129 |
|
|
2025
Q1 | $65.2M | Sell |
134,465
-15,373
| -10% | -$7.45M | 0.06% | 139 |
|
|
2024
Q4 | $60.3M | Buy |
149,838
+9,258
| +7% | +$3.73M | 0.05% | 138 |
|
|
2024
Q3 | $65.4M | Sell |
140,580
-27,036
| -16% | -$12.6M | 0.05% | 133 |
|
|
2024
Q2 | $78.6M | Buy |
+167,616
| New | +$78.6M | 0.06% | 123 |
|
|
2019
Q2 | – | Sell |
-424,845
| Closed | -$78.2M | – | 230 |
|
|
2019
Q1 | $78.2M | Sell |
424,845
-302,317
| -42% | -$55.6M | 0.09% | 107 |
|
|
2018
Q4 | $120M | Buy |
727,162
+132,435
| +22% | +$21.9M | 0.16% | 88 |
|
|
2018
Q3 | $115M | Buy |
594,727
+16,288
| +3% | +$3.14M | 0.12% | 89 |
|
|
2018
Q2 | $98.3M | Buy |
578,439
+31,744
| +6% | +$5.4M | 0.11% | 89 |
|
|
2018
Q1 | $89.1M | Buy |
546,695
+48,317
| +10% | +$7.87M | 0.1% | 88 |
|
|
2017
Q4 | $74.7M | Buy |
498,378
+6,547
| +1% | +$981K | 0.09% | 95 |
|
|
2017
Q3 | $74.8M | Buy |
491,831
+6,234
| +1% | +$948K | 0.09% | 92 |
|
|
2017
Q2 | $62.6M | Buy |
485,597
+31,483
| +7% | +$4.06M | 0.08% | 95 |
|
|
2017
Q1 | $49.7M | Sell |
454,114
-6,349
| -1% | -$694K | 0.07% | 96 |
|
|
2016
Q4 | $33.9M | Buy |
+460,463
| New | +$33.9M | 0.06% | 101 |
|